Publication Date
| In 2026 | 0 |
| Since 2025 | 0 |
| Since 2022 (last 5 years) | 0 |
| Since 2017 (last 10 years) | 1 |
| Since 2007 (last 20 years) | 1 |
Descriptor
| Anxiety | 1 |
| Behavior | 1 |
| Biochemistry | 1 |
| Drug Therapy | 1 |
| Females | 1 |
| Genetic Disorders | 1 |
| Neurological Impairments | 1 |
| Severe Disabilities | 1 |
Source
| American Journal on… | 1 |
Author
| Byiers, Breanne J. | 1 |
| Ehrhardt, Michael J. | 1 |
| Feyma, Timothy | 1 |
| Panoskaltsis-Mortari, Angela | 1 |
| Payen, Ameante | 1 |
| Symons, Frank J. | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkByiers, Breanne J.; Payen, Ameante; Feyma, Timothy; Panoskaltsis-Mortari, Angela; Ehrhardt, Michael J.; Symons, Frank J. – American Journal on Intellectual and Developmental Disabilities, 2020
Rett syndrome (RTT) is a severe neurodevelopmental disorder resulting from mutations of the MECP2 gene. Hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis and abnormal stress responses have been observed in animal models of RTT, but little is known about HPA axis function among individuals with RTT. Diurnal salivary cortisol patterns…
Descriptors: Neurological Impairments, Genetic Disorders, Females, Severe Disabilities
